Boussard & Gavaudan Investment Management’s Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 BHIL.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-20,000
Closed -$28 152
2021
Q3
$28 Buy
+20,000
New +$28.2K ﹤0.01% 133

Other funds holding BHIL.WS

Boussard & Gavaudan Investment Management's BHIL.WS Position: Q4 2021 in Review

Boussard & Gavaudan Investment Management sold out of Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 (BHIL.WS) in Q4 2021, closing a stake of 20,000 shares — an estimated $28 sold.

Boussard & Gavaudan Investment Management first reported a position in BHIL.WS in Q3 2021 and held it in 1 quarter. The position peaked at $28 in Q3 2021. 43 funds tracked by Wall St. Rank hold BHIL.WS as of Q4 2021.

  • Boussard & Gavaudan Investment Management reported no remaining Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 position as of Q4 2021 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 20,000 Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 shares in Q4 2021, an estimated $28.
  • Boussard & Gavaudan Investment Management first reported a position in Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 in Q3 2021 and held it in 1 quarter.
  • Boussard & Gavaudan Investment Management's Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 position peaked at $28 in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 as of Q4 2021.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2021, filed 10 Feb 2022.